checkAd

     125  0 Kommentare Tecan to present at upcoming Investor Conferences

    Männedorf, Switzerland, January 8, 2024 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will attend and present at the following investor conferences this week:

    42nd Annual J.P. Morgan Healthcare Conference, San Francisco
    Date: 10 January 2024
    Presentation: 09:00 am PST (6:00 pm CET)
    Presenter: Dr. Achim von Leoprechting, CEO, Tecan
    Additional participant: Tania Micki, CFO
    Webcast live under the "Investor Relations" tab of Tecan's website www.tecan.com
    A replay of the webcast will be available after the presentation and will remain available for 30 days.

    Baader Helvea Swiss Equities Conference, Bad Ragaz
    Date: 11 January 2024
    Participants: Klaus Lun, EVP, Head of the Life Sciences Business division
            Ralf Griebel, EVP, Head of the Partnering Business division
            Martin Brändle, SVP, Corp. Comm. & Investor Relations
    Not webcasted        

    Octavian Seminar 2024, Davos
    Date: 12 January 2024
    Participants: Klaus Lun, EVP, Head of the Life Sciences Business division
            Ralf Griebel, EVP, Head of the Partnering Business division
            Martin Brändle, SVP, Corp. Comm. & Investor Relations
    Not webcasted        

    About Tecan
    Tecan (www.tecan.com) improves people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has more than 3,500 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2022, Tecan generated sales of CHF 1,144 million (USD 1,192 million; EUR 1,144 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
             

    For further information:

    Tecan Group
    Martin Braendle
    Senior Vice President, Corporate Communications & IR
    Tel. +41 (0) 44 922 84 30
    Fax +41 (0) 44 922 88 89
    investor@tecan.com
    www.tecan.com

     

    Attachment





    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Tecan to present at upcoming Investor Conferences Männedorf, Switzerland, January 8, 2024 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will attend and present at the following investor conferences this week: 42nd Annual J.P. Morgan Healthcare Conference, San …